TYP 5.00% 1.9¢ tryptamine therapeutics limited

Ann: Progress Points To Partnering Readiness, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. sle
    10,816 Posts.
    lightbulb Created with Sketch. 349
    And of course this parting comment for people to read between the lines:

    “I founded Exopharm as a global company with a ‘Big Idea’: that EV medicines would
    transform healthcare. Our partnering discussions go around the clock – Europe, North
    America, Japan and Asia Pacific. Our office in Basel will be ready to provide support to
    partners and customers in Europe. Exopharm’s commercial team has greatly improved
    our visibility and established our credibility in the industry over the past 12 months. I see
    2021 as ‘The Year We LEAP’,” said Dr Ian Dixon, Founder and Managing Director.

 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
-0.001(5.00%)
Mkt cap ! $20.69M
Open High Low Value Volume
2.0¢ 2.0¢ 1.9¢ $18.75K 951.1K

Buyers (Bids)

No. Vol. Price($)
2 183839 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1000000 1
View Market Depth
Last trade - 11.43am 11/10/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.